Adverse Events of Special Interest (AESIs) for Covid-19 Vaccines Surveillance

Public Health Ontario Adverse Events of Special Interest (AESIs) for COVID-19 Vaccines Surveillance Following the authorization of novel Coronavirus Disease 2019 (COVID-19) vaccines in Canada, post- marketing surveillance is being conducted to monitor the safety of these new vaccines throughout the implementation of the immunization program. Provincial reporting of adverse events following immunization (AEFIs) to […]